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ABSTRAK
Stunting pada anak merupakan masalah gizi yang cukup signifikan di negara-negara berkembang seperti 
Indonesia. Stunting dapat memengaruhi perkembangan otak dan fungsi kognitif. Beberapa studi menyebutkan 
bahwa stunting juga meningkatkan risiko kejadian obesitas saat dewasa dan hal ini berkaitan dengan pengaruhnya 
pada efisiensi metabolik. Anak-anak yang mengalami stunting memiliki resting energy expenditure yang lebih 
rendah dibandingkan dengan anak-anak yang tidak mengalami stunting. Anak dengan stunting juga memiliki 
respiratory quotient yang lebih tinggi dimana hal ini menandakan tingginya penggunaan karbohidrat sebagai 
sumber energi dibandingkan dengan penggunaan lemak. Mekanisme inilah yang diperkirakan memperantarai 
hubungan antara stunting dengan obesitas yaitu rendahnya oksidasi lemak serta kecenderungan yang lebih 
tinggi untuk menyimpan lemak. 
Review ini membahas status penelitian terbaru di bidang nutrigenetik mengenai hubungan antara stunting 
pada anak dan kejadian obesitas di saat dewasa. Diperkirakan bahwa anak dengan stunting lebih mudah 
mengalami obesitas karena memiliki metabolic rate yang rendah. Beberapa gen telah diteliti dan gen yang 
berkaitan dengan mekanisme kerja ghrelin diketahui terlibat pada fenomena ini. 
Kata kunci: stunting, obesitas, ghrelin, growth hormone secretague receptor (GHSR), gen polimorfisme.
ABSTRACT
Stunting or short stature in children is a significant nutritional problem in developing and underdeveloped 
countries. Stunting during childhood might affect brain development and impair development cognitive function. 
Additionally, this condition associated with the increased risk for obesity during adulthood. Several studies 
have shown that the increment risk of obesity and overweight in children with a short stature was due to their 
metabolic efficiency. Children with stunting have lower resting energy expenditure compared to non stunting 
children. Additionally, stunted children has higher respiratory quotient and carbohydrate oxidation but lower 
fat oxidation compared to non-stunting children. These results might explain why stunted children easily become 
obese, which is due to lower fat oxidation and leading to tendency to store fat.
This review discussed the current status on studies in the nutrigenetic aspects of the relationship between 
stunting in the childhood and obesity in adulthood. I hypothesized that stunted children are more likely to become 
obese in their later life because they have lower metabolic rate and higher tendency of fat storage. There are 
several candidate genes and pathway involved in obesity and I suspected that ghrelin and its receptor growth 
hormone secretague receptor (GHSR) were responsible.
Keywords: stunting, obesity, ghrelin, growth hormone secretague receptor (GHSR), gene polymorphism.
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INTRODUCTION
Stunting or short stature is a significant 
nutritional problem especially in developing 
and underdeveloped countries. In 2010, the 
worldwide prevalence of stunting in under five 
years old children was 27%.1 Although the 
global trend of stunting declined in the past two 
decades, several countries still have remaining 
high prevalence of stunting. It was reported 
that in India, the prevalence of stunting reached 
48%2 while in Indonesia the prevalence of 
stunting was 37.2%.3 It is important to discuss 
the impact of stunting as a risk factor for obesity 
because the world prevalence of obesity itself 
increases remarkably in the past few decades. 
The increasing rate of obesity is also seen in the 
developing countries such as Indonesia. The 
Ministry of Health reported that the prevalence 
of overweight and obesity in Indonesia is also 
increasing. In 2013, the prevalence of overweight 
and obesity in women were 32.9% while in men 
were 19.7%.3 It is also important to prevent the 
further increment of obesity because its disease 
manifestation such as diabetes mellitus and 
cardiovascular diseases4 as well as its significant 
economic burden.
There are several consequences on the effect 
of stunting during childhood. First, stunting 
might affect brain development and impair 
development of cognitive function.5 Second, 
stunting in childhood associated with the risk 
factor for obesity during adulthood. Although it 
is still a controversy, several investigations were 
leading to the hypothesis that childhood stunting 
associated with increased risk of obesity. It was 
before shown that there was an increment in the 
risk of obesity and overweight in stunted children 
and adolescents.6–10 Children (2-4 years old) 
with stunting had much higher body mass index 
(BMI), percent body fat and waist-to-hip ratio 
compared to the non-stunting children.11 A study 
in Brazilian children and adolescents showed 
that there was a connection between malnutrition 
during childhood (weight and height for-age) 
and obesity in adolescence and adulthood.12 The 
correlation between lower stature and higher 
incidence of obesity was also seen in a cross-
sectional study in Germany.13
Several studies have reported that the 
increment of risk of obesity and overweight 
in children with a short stature is associated 
with their metabolic properties. The possible 
mechanism has been reviewed before.14 It was 
shown that stunted school girls had higher 
susceptibility to gain weight from a high fat diet 
compared to non-stunted girls.15 Hoffman et al.16 
investigated metabolic properties of pre-pubertal 
boys and girls with and without stunting and 
showed that children with stunting have lower 
resting energy expenditure compared to non 
stunting children. Stunted children has higher 
respiratory quotient and carbohydrate oxidation 
but lower fat oxidation compared to non-stunting 
children. These results might explain how stunted 
children tend to become obese. This is because 
they have lower fat oxidation during fasting 
which lead to tendency to store fat instead of 
using them to produce energy.
This review discusses current status of 
research on the nutrigenetic aspect of the 
relationship between stunting in the childhood 
and obesity in adulthood. In this paper we 
hypothesized that the connection between 
stunting and obesity was due to low metabolic 
rate and higher tendency of fat storage. There 
are several candidate genes and pathway that 
are involved in obesity and we suspected that 
ghrelin and its receptor namely growth hormone 
secretagogue receptor (GHSR) were responsible.
GHRELIN AND LIPID METABOLISM
Ghrelin is a stomach derived hormone 
composed with 28 amino acids. This peptide is 
not only has orexigenic effect but also involved 
in human lipid metabolism. Because ghrelin 
was associated with promotion of feeding and 
adiposity, several studies showed this protein 
level was associated with body weight.17–19 In 
human, ghrelin level reduced in obesity and 
raised in anorexia nervosa.20,21 In animal model, 
ghrelin or ghrelin receptor knockout mice model 
were protected from diet-induced obesity.22,23
Ghrelin works through activation of growth 
hormone secretagogue receptor 1a (GHSR-
1a). This receptor is highly expressed in 
hypothalamus region that regulate feeding 
and body weight homeostasis.24,25 It has been 
investigated that the effect of ghrelin was via the 
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orexigenic neuropeptide agouti related protein 
(AGRP) and neuropeptie (NPY) in the activity-
regulated cytoskeleton associated protein (ARC). 
Additionally, ghrelin also affect body fat though 
regulation of two important lipid metabolism 
pathways: de novo lipogenesis and fatty acid 
oxidation.25
The raised ghrelin level increased mRNA 
expression of enzyme involved in de novo 
lipogenesis such as lipoprotein lipase (LPL), 
fatty acid synthase (FAS) and stearoyl-CoA 
desaturase (SCD 1).  Ghrelin also induced 
reduction in carnitine palmitoyltransferase 1 
(CPT 1) expression, an important protein that 
involved in regulation of fatty acid oxidation. 
The end process of this reaction is that the body 
tend to store fat and not using it for energy 
usage25 and because ghrelin level increased 
during fasting period, this metabolic process 
make sure that our metabolism is in higher 
energy efficiency. This is an human adaptation 
towards low food supply to decrease negative 
energy balance.26
GHRELIN IN STUNTING AND OBESITY
The role of ghrelin on growth in childhood and 
development of stunting are still controversial. 
In the early investigation of the physiology of 
ghrelin in human, it was stated that ghrelin level 
is varied depend on stage of development of 
the children. Ghrelin level during pre-pubertal 
stage was higher than those in pubertal stage.27 
Interestingly, ghrelin level was negatively 
correlated with growth stimulating hormones 
such as insulin like growth factor-I (IGF-I) 
leading to an assumption that reduction ghrelin 
level during late puberty is responsible for 
acceleration of growth within the period. 
However, in the study they did not found the 
correlation between ghrelin level and height in 
healthy children and adolescents.27
In order to further investigate the role of 
ghrelin on growth and stature, a study was 
done to compared ghrelin level in children with 
constitutional delay of growth (and puberty) 
(CDGP) (height standard deviation score/SDS 
< -2), familial short stature (FSS) (height SDS 
<-2) and normal height (height SDS >-2 and 
<2)(28). In the study they showed that children 
with CDGP and FSS had a much higher ghrelin 
compared to normal height children.28 However, 
these findings were different with the finding 
from Sen et al.29 In the study they showed that 
there were no significant differences in fasting 
ghrelin level or postprandial ghrelin level 
in children with CDGP compared to normal 
children, although there is a trend that children 
with CDGP had higher ghrelin level compared 
to normal children.
The association between ghrelin and obesity 
is controversial and to date there is no exact 
evidence on whether ghrelin induces obesity or 
the state obesity induces disturbance in ghrelin 
production/action. One of the earliest reports 
on ghrelin level in human obesity was done 
by Tschöp et al.20 They compared the plasma 
ghrelin concentration of obese and normal weight 
individuals and found that ghrelin concentration 
in obese Caucasian was significantly lower 
compared to those in their normal weight 
counterpart. The result from this study was 
different with those found Cruz-Domínguez et 
al.30 who showed that ghrelin concentration in 
obese individuals (with BMI >30 and <40) was 
significantly higher compared to their normal 
counterpart.
There were some explanations about the 
differences between studies. First, it seems that 
ethnicity has a role in the level of ghrelin since 
Tschöp et al.20 suggested that Caucasians have 
a significantly higher ghrelin level compared to 
the Pima Indians. Second, the degree of insulin 
resistance or diabetes mellitus between obese 
individuals seems also have an influence on 
regulating ghrelin production. This was due 
to the fact that obese individuals with diabetes 
mellitus had a significantly lower ghrelin level 
compared to those without diabetes mellitus.30
Additionally, it is very important to 
acknowledge that to work properly, ghrelin 
requires enzyme activation and sufficient 
receptor sensitivity. Ghrelin should undergo 
an O-n-octanoylation process before activating 
GHSR. This process is mediated by an enzyme 
called ghrelin  O-acyl  transferase (GOAT) with 
the acyl originated from medium-chain fatty 
acids.31–33 In addition to GOAT, GHSR is also 
an important part that regulates the phenotypical 
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function of ghrelin. This is supported by the 
report showed that ghrelin antagonists and 
GHSR gene knockout model has ability to reduce 
ghrelin induced physiological function.23,33,34
GHSR GENE POLYMORPHISM IN STUNTING 
AND OBESITY
The role of single nucleotide polymorphism 
(SNP) of GHSR on GHSR activity and obesity 
has been extensively studied in the past ten years. 
Inoue et al35 screened for genetic mutations of 
GHSR gene in Japanese patients with familial 
short stature and growth hormone deficiency. In 
the study they discovered 4 mutation points that 
were connected with GHSR activity including 
ΔQ36 (106-108 del CAG), P108L (323C>T), 
C173R (517T>C), and D246A (737A>C). Most 
of the mutations have a significant impact on 
constitutive signaling activity of GHSR. This 
was done through various mechanism including 
intracellular retention; reduction in binding 
activity to ghrelin; and impaired agonist- and 
inverse agonist – stimulated receptor signal. 
Those data then supported by findings done 
by Pugliese-Pires et al36 who showed that 
transfection with a plasmid encoding Ser84Ile 
mutation induce reduction of GHSR expression 
at the surface of HEK293 cells.
There were some reports on clinical 
phenotypes of GHSR gene polymorphism 
especially on individual’s stature and obesity. 
The reports on genetic association between 
GHSR polymorphism, stature and obesity have 
been reviewed elsewhere.37 A large cohort study 
conducted by Riedl et al(38) in Australia followed 
1362 children from birth to 10 years old. In the 
study they showed that there were 2 important 
SNPs including SNPs in rs482204 and rs562416. 
TT genotype in rs482204 vs TC/CC was associated 
with greater stature across the entire observation 
period while TT genotype in rs562416 vs TG/GG 
was correlated positively with tall stature at 3, 8, 
and 10 years old. These associations were not seen 
in French population.39 In our study, we showed 
that GHSR gene polymorphisms were slightly 
to be associated with stature in obese adolescent 
girls.40 (Figure 1)
Despite the fact that only limited studies 
reporting the relationship between GHSR gene 
polymorphism and obesity, few of the results 
were tend to be controversial.37 It was showed 
that GHSR gene knock out model had a different 
properties in energy intake and adiposity.23 
GHSR-null mice were failed to response to 
ghrelin signal thus eat less food and store less 
fat compared to the wild type mice. One of the 
In this study we analyzed two SNPs in GHSR include rs292216 and rs509035. In our previous study we showed the trend that 
AA genotype in GHSR gene rs292216 were more likely to have lower Z score compared to those with AT and TT. Because all 
subjects were adoloescents, height was analyzed using a height-to-age Z score. p-value was obtained from t-test by comparing 
mean height-for-age Z score between AA genotype and AT+TT genotype.
Figure 1. The association between height-for-age Z score and GHSR gene polymorphism in obese female adolescents.
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earlier investigations on SNP in GHSR and 
obesity in human was done by Baessler et al.41 
who showed that SNPs and haplotypes within 
GHSR gene region were associated with obesity. 
Interestingly, this result cannot be replicated by 
studies from European region.41 Gueorguiev et 
al.42 showed that GHSR gene polymorphism 
rs572169 was significantly associated with 
obesity but the significance the diminished after 
corrected for multiple comparisons.
In this review, author proposed an idea that 
ghrelin plays an important role in the connection 
between stunting in childhood and obesity in 
adulthood. This was based on trend that stunted 
children and obese adults possessed similar 
pattern on ghrelin concentration and GHSR 
sensitivity. Author also proposed that GHSR gene 
polymorphism was previously reported to induce 
lack of ghrelin sensitivity. Unfortunately, today 
there was no study that clearly demonstrated that 
GHSR gene polymorphism is induces stunting 
in children and obesity in adulthood by affecting 
individuals ghrelin concentration.
In the future, it will be interesting to clarify 
the role of GHSR gene polymorphism and 
ghrelin sensitivity on stunting children followed 
until adults. Since ghrelin appears to have role 
in development of short stature in children, 
developing a treatment targeting ghrelin and its 
receptor pathway could be potential to be done in 
the future. This is probably could be used as one 
of the treatment for stunted children to prevent 
future development of obesity.
CONCLUSION
In summary, author supported the idea that 
stunted children were at higher risk of obesity in 
their adult life. This was due to the shifting in their 
metabolic properties which are likely to store fat 
and not using fat for the source energy. Ghrelin 
was believed to have a role in this metabolic 
property because studies showed that there is 
disturbance in ghrelin concentration in stunted 
children. The disturbance of ghrelin sensitivity 
was associated with GHSR gene polymorphism 
and because GHSR gene polymorphism is 
associated ghrelin sensitivity, author suggested 
that this gene can explain the connection between 
stunting in childhood and obesity in adulthood.
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